基因检测公司GeneDx Holdings（股票代码：WGS）今日盘中大幅上涨5.15%，表现显著强于大盘。
消息面上，公司发布的第四季度财务业绩超出市场预期，是推动股价上涨的主要原因。根据报告，GeneDx第四季度营收达到1.21亿美元，高于分析师预计的1.204亿美元；调整后每股利润为14美分，也超出了每股11美分的预期。此外，公司核心业务外显子组和基因组测试收入增长强劲，同比增幅达32%，至1.04亿美元。
公司同时重申了对2026财年的收入展望，预计在5.4亿至5.55亿美元之间，其中外显子组和基因组测试收入预计将增长33%至35%。Piper Sandler的分析师指出，GeneDx在快速增长且不断扩大的罕见病检测市场中拥有独特的先发优势，增强了投资者信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.